What is a Placed Based Impact Acceleration Account (PBIAA)? In October 2023, the Engineering and Physical Sciences Research Council (EPSRC) released a call for round two of their PBIAA scheme, which is intended to enhance the capabilities of research and innovation clusters across the UK to drive economic and societal...
Nine coveted awards up for grabs at Medilink Midlands Business Awards 2024
Applications are now open for Medilink Midlands’ Business Awards which will once again celebrate the work and achievements of life sciences companies across the Midlands. With nine categories from Start-Up to Outstanding Achievement, the 2024 awards are set to be bigger and better than ever and will highlight some of...
Influx of promotions and new starters at Cellomatics signals next successful phase for award winning business
Specialist preclinical contract research organisation (CRO) Cellomatics Biosciences has heralded the start of its next successful phase with four promotions and eight new arrivals. Dr Shailendra Singh, CEO of Cellomatics Biosciences, comments: “Capitalising on our existing strengths and internal team expertise, we intend to further consolidate our position as a...
Medilink Midlands CEO Melanie Davidson gives expert insight on the Rosalind Franklin Laboratory
The sale of a vast COVID-19 testing lab in the UK is an opportunity to develop the start-up ecosystem in the Midlands region. But what form of repurposing would serve the region best: a general life sciences hub, or a specialist research and innovation centre? Both options have been floated...
Long term cost savings and quality outcomes for the NHS
New findings from Spirit Health’s prescribing change programmes Research released - demonstrating how a prescribing change program can deliver long-term cost efficiencies and improve patient treatment Greater Manchester achieved a significant 29.6% cost reduction in self-monitoring of blood glucose units over the 6 years Outperforming the average cost reduction in...
Upperton announces expansion into sterile drug manufacturing with new £5million GMP facility
Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions (Upperton) has announced a £5million investment to expand operations into small-scale sterile fill-finish. After completing the build and qualification of a new 50,000sqft GMP facility during 2023, the UK-based CDMO announces further expansion at its Trent Gateway site to...
Implementation of the Future Regulations – A view on the Roadmap
In this article Medilink Midlands' Head of Connectivity Chris Dyke shares his thoughts on the Implementation of the Future Regulations. In viewing this new document (9 Jan 2024) the first part of Implementation of the Future Regulations provides additional clarity to what has been previously announced i.e. ‘Transitional Arrangements’ and...
Patron Spotlight: Health Innovation East Midlands
Medilink Midlands offers Patronage to prominent organisations within the Midlands that recognise and demonstrate the importance of life sciences to the region, and that appreciate the positive contribution that Medilink makes to the sector through our diverse programme of events and business support activities. Health Innovation East Midlands (formerly East...
Medilink Midlands awarded Investors in People accreditation
Medilink Midlands has been awarded the ‘We invest in people’ standard accreditation by Investors in People, the UK’s leading people management business improvement standard. The accolade means principles and practices around supporting people are in place at Medilink Midlands and everyone understands how to use them to make work better....
Happy New Year and a warm welcome to 2024 from everybody at Medilink Midlands.
We hope you all had an enjoyable time over the holidays and, like us, are keen to see what 2024 has in store. To kick off the year, we wanted to highlight a few dates for your diaries. Firstly, we’re hosting our Annual Business Awards at the Athena, Leicester this...